-
Loading metrics
Open Access
Peer-reviewed
Research Article
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
-
Kathleen M. C. Sullivan ,
Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing
* E-mail: calabiyau@mac.com (KMCS); zhang.penglie@gmail.com (PZ)
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Marta Vilalta,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Linda S. Ertl,
Roles Investigation, Methodology, Supervision, Writing – review & editing
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Yu Wang,
Roles Investigation, Methodology, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Carolyn Dunlap,
Roles Investigation, Methodology
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Karen Ebsworth,
Roles Investigation, Methodology, Writing – review & editing
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Bin N. Zhao,
Roles Investigation, Methodology
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Shijie Li,
Roles Investigation, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Yibin Zeng,
Roles Investigation, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Zhenhua Miao,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Pingchen Fan,
Roles Investigation, Methodology
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Venkat Mali,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Christopher Lange,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Darren McMurtrie,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Ju Yang,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Rebecca Lui,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Ryan Scamp,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Vicky Chhina,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Alice Kumamoto,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Simon Yau,
Roles Investigation, Methodology, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Ton Dang,
Roles Investigation, Methodology
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Ashton Easterday,
Roles Investigation
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Shirley Liu,
Roles Investigation, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Shichang Miao,
Roles Investigation, Methodology, Supervision
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Israel Charo,
Roles Supervision, Writing – review & editing
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ -
Thomas J. Schall,
Roles Conceptualization, Resources, Supervision, Writing – review & editing
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ - [ ... ],
-
Penglie Zhang
Roles Conceptualization, Supervision, Writing – review & editing
* E-mail: calabiyau@mac.com (KMCS); zhang.penglie@gmail.com (PZ)
Affiliation ChemoCentryx, Inc., San Carlos, California, United States of America
⨯ - [ view all ]
- [ view less ]
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
- Kathleen M. C. Sullivan,
- Marta Vilalta,
- Linda S. Ertl,
- Yu Wang,
- Carolyn Dunlap,
- Karen Ebsworth,
- Bin N. Zhao,
- Shijie Li,
- Yibin Zeng,
- Zhenhua Miao
![PLOS](/resource/img/logo-plos.png)
- Published: June 7, 2023
- https://doi.org/10.1371/journal.pone.0286724